The Journal of Urology
Volume 171, Issue 2, Supplement , Pages S36-S40 , February 2004

Epidemiology of Inflammation and Prostate Cancer

  • ELIZABETH A. PLATZ

      Affiliations

    • Corresponding Author InformationCorrespondence: Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 615 N. Wolfe St., Room E6138, Baltimore, Maryland 21205 (telephone: 410-614-9674; FAX: 410-614-2632).
    • ,
  • ANGELO M. De MARZO

      Affiliations

    • Financial interest and/or other relationship with Merck.

REFERENCES 

  1. Coussens LM , Werb Z . Inflammation and cancer . Nature . 2002;420:860
  2. Munger K , Howley PM . Human papillomavirus immortalization and transformation functions . Virus Research . 2002;89:213
  3. O'Brien PM , Saveria Campo M . Evasion of host immunity directed by papillomavirus-encoded proteins . Virus Res . 2002;88:103
  4. American Cancer Society: Cancer Facts & Figures, 2003. 2003
  5. Schatteman PH , Hoekx L , Wyndaele JJ , Jeuris W , Van Marck E . Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis . Eur Urol . 2000;37:404
  6. Gerstenbluth RE , Seftel AD , MacLennan GT , Rao RN , Corty EW , Ferguson K , et al.   Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation . J Urol . 2002;167:2267
  7. Di Silverio F , Gentile V , de Matteis A , Mariotti G , Giuseppe V , Luigi PA , et al.   Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis . Eur Urol . 2003;43:164
  8. Nickel JC , Downey J , Young I , Boag S . Asymptomatic inflammation and/or infection in benign prostatic hyperplasia . BJU Int . 1999;84:976
  9. Carver BS , Bozeman CB , Williams BJ , Venable DD . The prevalence of men with National Institutes of Health Category IV prostatitis and association with serum prostate specific antigen . J Urol . 2003;169:589
  10. Zugen A . A big study yields big questions . N Engl J Med . 2003;349:213
  11. Franks LM . Atrophy and hyperplasia in the prostate proper . J Pathol Bacteriol . 1954;68:617
  12. Liavag I . Atrophy and regeneration in the pathogenesis of prostatic carcinoma . Acta Pathol Microbiol Scand . 1968;73:338
  13. Feneley MR , Young MP , Chinyama C , Kirby RS , Parkinson MC . Ki-67 expression in early prostate cancer and associated pathological lesions . J Clin Pathol . 1996;49:741
  14. Ruska KM , Sauvageot J , Epstein JI . Histology and cellular kinetics of prostatic atrophy . Am J Surg Pathol . 1998;22:1073
  15. De Marzo AM , Marchi VL , Epstein JI , Nelson WG . Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis . Am J Pathol . 1999;155:1985
  16. Putzi MJ , De Marzo AM . Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia . Urology . 2000;56:828
  17. McNeal JE , Bostwick DG . Intraductal dysplasia: a premalignant lesion of the prostate . Hum Pathol . 1986;17:64
  18. Parsons JK , Nelson CP , Gage WR , Nelson WG , Kensler TW , De Marzo AM . GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue . Prostate . 2001;49:30
  19. Lee WH , Morton RA , Epstein JI , Brooks JD , Campbell PA , Bova GS , et al.   Cytidine methylation of regulatory sequences near the p-class glutathione S-transferase gene accompanies human prostatic carcinogenesis . Proc Natl Acad Sci . 1994;91:11733
  20. Brooks JD , Weinstein M , Lin X , Sun Y , Pin SS , Bora GS , et al.   CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia . Cancer Epidemiol Biomarkers Prev . 1998;7:531
  21. Gordon S . Alternative activation of macrophages . Nat Rev Immunol . 2002;3:23
  22. Gage WR , Marchi VK , Nelson WG , De Marzo AM . Macrophages and inducible nitric oxide synthetase in proliferative inflammatory atrophy of the prostate . J Urol . 2000;163(suppl.):24; abstract 104
  23. Burke B , Tang N , Corke KP , Tazzyman D , Ameri K , Wells M , et al.   Expression of HIF-Ia by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy . J Pathol . 2002;196:204
  24. Dennis LK , Dawson DV . Meta-analysis of measures of sexual activity and prostate cancer . Epidemiology . 2002;13:72
  25. Hayes RB , Pottern LM , Strickler H , Rabkin C , Pope V , Swanson GM , et al.   Sexual behaviour, STDs and risks for prostate cancer . Br J Cancer . 2000;82:718
  26. Dillner J , Knekt P , Boman J , Lehtinen M , Af Geijersstam V , Sapp M , et al.   Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer . Int J Cancer . 1998;75:564
  27. Hisada M , Rabkin CS , Strickler HD , Wright WE , Christianson RE , van den Berg BJ . Human papillomavirus antibody and risk of prostate cancer . JAMA . 2000;283:340
  28. Munoz N , Bosch FX , de Sanjose S , Herrero R , Castellsague X , Shah KV , et al.   Epidemiologic classification of human papillomavirus types associated with cervical cancer . N Engl J Med . 2003;348:518
  29. Strickler HD , Burk R , Shah K , Viscidi R , Jackson A , Pizza G , et al.   A multifaceted study of human papillomavirus and prostate carcinoma . Cancer . 1998;82:1118
  30. Sitas F , Carrara H , Beral V , Newton R , Reeves G , Bull D , et al.   Antibodies against human herpesvirus 8 in black South African Patients with cancer . N Engl J Med . 1999;340:1863
  31. Baker LH , Mebust WK , Chin TD , Chapman AL , Hinthorn D , Towle D . The relationship of herpesvirus to carcinoma of the prostate . J Urol . 1981;125:370
  32. Herbert JT , Birkhoff JD , Feorino PM , Caldwell GG . Herpes simplex virus type 2 and cancer of the prostate . J Urol . 1976;116:611
  33. Griffiths TRL , Mellon JK . Human papillomavirus and urological tumours: II. role in bladder, prostate, renal and testicular cancer . BJU Int . 2000;85:211
  34. Grinstein S , Preciado MV , Gattuso P , Chabay PA , Warren WH , de Matteo E . Demonstration of Epstein-Barr virus in carcinomas of various sites . Cancer Res . 2002;62:4876
  35. Hochreiter WW , Duncan JL , Schaeffer AJ . Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction . J Urol . 2000;163:127
  36. Weidner W , Diemer T , Huwe P , Rainer H , Ludwig M . The role of Chlamydia trachomatis in prostatitis . Int J Antimicrob Agents . 2002;19:466
  37. Roberts RO , Lieber MM , Rhodes T , Girman CJ , Bostwick DG , Jacobsen SJ . Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men . Urology . 1998;51:578
  38. Krieger JN , Nyberg JL , Nickel JC . NIH consensus definition and classification of prostatitis . JAMA . 1999;282:236
  39. Skerk V , Schonwald S , Krhen I , Markovinovic L , Beus A , Kazmanovic NS , et al.   Aetiology of chronic prostatitis . Int J Antimicrob Agents . 2002;19:471
  40. Krieger JN , Riley DE . Prostatitis: what is the role of infection . Int J Antimicrob Agents . 2002;19:475
  41. Dennis LK , Lynch CF , Torner JC . Epidemiologic association between prostatitis and prostate cancer . Urology . 2002;60:78
  42. National Kidney and Urologic Diseases Information Clearinghouse: Prostatitis: Disorders of the Prostate: NIH Publication No. 00-4553, vol. 2003, 2000
  43. Schaeffer AJ , Knauss JS , Landis JR , Propert KJ , Alexander RB , Litwin MS , et al.   Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study . J Urol . 2002;168:1048
  44. True LD , Berger RE , Rothman I , Ross SO , Krieger JN . Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study . J Urol . 1999;162:2014
  45. Siegall CB , Schwab G , Nordan RP , FitzGerald DJ , Pastan I . Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells . Cancer Res . 1990;50:7786
  46. Okamoto M , Lee C , Oyasu R . Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro . Cancer Res . 1997;57:141
  47. Twillie DA , Eisenberger MA , Carducci MA , Hseih WS , Kim WY , Simons JW . Interleukin-6: a candidate mediator of human prostate cancer morbidity . Urology . 1995;45:542
  48. Lin DL , Whitney MC , Yao Z , Keller ET . Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression . Clin Cancer Res . 2001;7:1773
  49. Chung TD , Yu JJ , Spiotto MT , Bartkowski M , Simons JW . Characterization of the role of IL-6 in the progression of prostate cancer . Prostate . 1999;38:199
  50. Giri D , Ozen M , Ittmann M . Interleukin-6 is an autocrine growth factor in human prostate cancer . Am J Pathol . 2001;159:2159
  51. Trautner K , Cooper EH , Haworth S , Ward AM . An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer . Scand J Urol Nephrol . 1980;14:143
  52. McMillan DC , Talwar D , Sattar N , Underwood M , O'Reilly DS , McArdle C . The relationship between reduced vitamin antioxidant concentrations and the system inflammatory response in patients with common solid tumours . Clin Nutr . 2002;21:161
  53. Latif Z , McMillan DC , Wallace AM , Sattar N , Mir K , Jones G , et al.   The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate specific antigen and C-reactive protein with disease stage in prostate cancer . BJU Int . 2002;89:396
  54. Shariat SF , Andrews B , Kattan MW , Kim J , Wheeler TM , Slawin KM . Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis . Urology . 2001;58:1008
  55. Nakashima J , Tachibana M , Horiguchi Y , Oya M , Ohigashi T , Asakura H , et al.   Serum interleukin 6 as a prognostic factor in patients with prostate cancer . Clin Cancer Res . 2000;6:2702
  56. Drachenberg DE , Elgamal AA , Rowbotham R , Peterson M , Murphy GP . Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer . Prostate . 1999;41:127
  57. Adler HL , McCurdy MA , Kattan MW , Timme TL , Scardino PT , Thompson TC . Elevated levels of circulating interleukin-6 and transforming growth factor-b1 in patients with metastatic prostatic carcinoma . J Urol . 1999;161:182
  58. Wise GJ , Marella VK , Talluri G , Shirazian D . Cytokine variations in patients with hormone treated prostate cancer . J Urol . 2000;164:722
  59. Veltri RW , Miller MC , Zhao G , Ng A , Wright GM , Marley GL , et al.   Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer . Urology . 1999;53:139
  60. Nakashima J , Tachibana M , Ueno M , Baba S , Tazaki H . Tumor necrosis factor and coagulopathy in patients with prostate cancer . Cancer Res . 1995;55:4881
  61. McCarron SL , Edwards S , Evans PR , Gibbs R , Dearnaley DP , Dowe A , et al.   Influence of cytokine gene polymorphisms on the development of prostate cancer . Cancer Res . 2002;62:3369
  62. Oh BR , Sasaki M , Perinchery G , Ryu SB , Park YI , Carroll P , et al.   Frequent genotype changes at −308, and 488 regions of the tumor necrosis factor-a (TNF-a) gene in patients with prostate cancer . J Urol . 2000;163:1584
  63. Silverman RH . Implications for RNase L in prostate cancer biology . Biochemistry . 2003;42:1805
  64. Carpten J , Nupponen N , Isaacs S , Sood R , Robbins C , Xu J , et al.   Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 . Nat Genet . 2002;30:181
  65. Casey G , Neville PJ , Plummer SJ , Xiang Y , Krumroy LM , Klein EA , et al.   RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases . Nat Genet . 2002;32:581
  66. Rokman A , Ikonen T , Seppala EH , Nupponen N , Autio V , Mononen N , et al.   Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer . Am J Hum Genet . 2002;70:1299
  67. Wang L , McDonnell SK , Elkins DA , Slager SL , Christensen E , Marks AF , et al.   Analysis of the RNASEL gene in familial and sporadic prostate cancer . Am J Hum Genet . 2002;71:116
  68. Coller S , Paulnock D . Signaling pathways initiated in macrophages after engagement of type A scavenger receptors . J Leukoc Biol . 2001;70:142
  69. Xu J , Zheng SL , Komiya A , Mychaleckyj JC , Isaacs SD , Hu JJ , et al.   Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk . Nat Genet . 2002;32:321
  70. Wiklund F , Jonsson BA , Goransson I , Bergh A , Gronberg H . Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22–23 . Hum Genet . 2003;112:414
  71. Xu J , Zheng L , Komiya A , Mychaleckyj JC , Isaacs SD , Chang B , et al.   Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk . Am J Hum Genet . 2003;72:208
  72. Nelson WG , de Marzo AM , De Weese TL . The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention . Urology . 2001;57(suppl.):39

PII: S0022-5347(05)62516-5

doi: 10.1097/01.ju.0000108131.43160.77

The Journal of Urology
Volume 171, Issue 2, Supplement , Pages S36-S40 , February 2004

Article Tools